The angiotensin II AT1-receptor antagonist candesartan reduces infarct size in pigs.

被引：0
|
作者：
Jalowy, A [1 ]
Schulz, R [1 ]
Post, H [1 ]
Dörge, H [1 ]
Weidenbach, R [1 ]
Behrends, M [1 ]
Heusch, G [1 ]
机构：
[1] Univ Hosp Essen, Dept Pathophysiol, Essen, Germany
来源：
FASEB JOURNAL | 1998年 / 12卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
6446
引用
收藏
页码：A1114 / A1114
页数：1
相关论文
共 50 条
  • [41] Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension
    Higashiura, K
    Ura, N
    Miyazaki, Y
    Shimamoto, K
    JOURNAL OF HUMAN HYPERTENSION, 1999, 13 (Suppl 1) : S71 - S74
  • [42] Effect of an angiotensin II receptor antagonist, candesartan, on insulin resistance and pressor mechanisms in essential hypertension
    K Higashiura
    N Ura
    Y Miyazaki
    K Shimamoto
    Journal of Human Hypertension, 1999, 13 : S71 - S74
  • [43] Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil
    Papademetriou, V
    Mammillot, P
    Redman, R
    Notargiacomo, A
    Narayan, P
    Lakshman, R
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 : S77 - S80
  • [44] Renal hemodynamic and hormonal responses to the angiotensin II antagonist candesartan
    Lansang, MC
    Osei, SY
    Price, DA
    Fisher, NDL
    Hollenberg, NK
    HYPERTENSION, 2000, 36 (05) : 834 - 838
  • [45] Candesartan, an angiotensin II type 1 receptor antagonist, inhibits pathological retinal neovascularization by downregulating VEGF receptor-2 expression
    Nakamura, Shinsuke
    Tsuruma, Kazuhiro
    Shimazawa, Masamitsu
    Hara, Hideaki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2012, 685 (1-3) : 8 - 14
  • [46] Candesartan cilexetil -: Antihypertensive angiotensin AT1 antagonist
    不详
    DRUGS OF THE FUTURE, 2001, 26 (07) : 696 - 697
  • [47] Hypotensive effect of angiotensin II after AT1-receptor blockade with losartan.
    Pawlak, R
    Chabielska, E
    Matys, T
    Wollny, T
    Pawlak, DG
    Buczko, W
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R277 - R277
  • [48] Multiple human Isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-Receptor
    Yamada, Akihiro
    Maeda, Kazuya
    Kamiyama, Emi
    Sugiyama, Daisuke
    Kondo, Tsunenori
    Shiroyanagi, Yoshiyuki
    Nakazawa, Hayakazu
    Okano, Teruo
    Adachi, Masashi
    Schuetz, John D.
    Adachi, Yasuhisa
    Hu, Zhuohan
    Kusuhara, Hiroyuki
    Sugiyama, Yuichi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (12) : 2166 - 2176
  • [49] Renal oxygenation during haemorrhage is not aggravated by angiotensin II AT1-receptor blockade
    Melville, J. M.
    Palm, F.
    Hultstrom, M.
    ACTA PHYSIOLOGICA, 2016, 216 (02) : 153 - 155
  • [50] Candesartan cilexetil, a novel angiotensin II antagonist reduces microalbuminuria inpatients with type II diabetes mellitus and mild hypertension.
    Forsblom, C
    Trenkwalder, P
    Dahl, K
    Mulder, H
    DIABETOLOGIA, 1997, 40 : 1438 - 1438
12345